Fibrinolysis and the control of blood coagulation
JC Chapin, KA Hajjar - Blood reviews, 2015 - Elsevier
Fibrin plays an essential role in hemostasis as both the primary product of the coagulation
cascade and the ultimate substrate for fibrinolysis. Fibrinolysis efficiency is greatly …
cascade and the ultimate substrate for fibrinolysis. Fibrinolysis efficiency is greatly …
Platelets and extracellular vesicles and their cross talk with cancer
S Lazar, LE Goldfinger - Blood, The Journal of the American …, 2021 - ashpublications.org
Platelets play significant and varied roles in cancer progression, as detailed throughout this
review series, via direct interactions with cancer cells and by long-range indirect interactions …
review series, via direct interactions with cancer cells and by long-range indirect interactions …
How I treat disseminated intravascular coagulation
M Levi, M Scully - Blood, The Journal of the American Society …, 2018 - ashpublications.org
Disseminated intravascular coagulation (DIC) is a condition characterized by systemic
activation of coagulation, potentially leading to thrombotic obstruction of small and midsize …
activation of coagulation, potentially leading to thrombotic obstruction of small and midsize …
Tumor lysis syndrome
SC Howard, CH Pui, RC Ribeiro - Renal Disease in Cancer Patients, 2014 - Elsevier
Tumor lysis syndrome (TLS) is a serious, sometimes life-threatening oncologic emergency
caused by rapid and massive cellular lysis and subsequent release of tumor cell contents …
caused by rapid and massive cellular lysis and subsequent release of tumor cell contents …
How to manage coagulopathies in critically ill patients
J Helms, T Iba, JM Connors, S Gando, M Levi… - Intensive care …, 2023 - Springer
Coagulopathy is a severe and frequent complication in critically ill patients, for which the
pathogenesis and presentation may be variable depending on the underlying disease …
pathogenesis and presentation may be variable depending on the underlying disease …
Acute promyelocytic leukemia (APL): remaining challenges towards a cure for all
M Stahl, MS Tallman - Leukemia & lymphoma, 2019 - Taylor & Francis
The application of all-trans retinoic acid (ATRA) and arsenic trioxide (ATO) has
revolutionized the treatment of acute promyelocytic leukemia (APL). More than 80–90% of …
revolutionized the treatment of acute promyelocytic leukemia (APL). More than 80–90% of …
Activation of a promyelocytic leukemia–tumor protein 53 axis underlies acute promyelocytic leukemia cure
Acute promyelocytic leukemia (APL) is driven by the promyelocytic leukemia (PML)–retinoic
acid receptor-α (PML-RARA) fusion protein, which interferes with nuclear receptor signaling …
acid receptor-α (PML-RARA) fusion protein, which interferes with nuclear receptor signaling …
The pathogenesis and management of the coagulopathy of acute promyelocytic leukaemia
KA Breen, D Grimwade, BJ Hunt - British journal of …, 2012 - Wiley Online Library
Coagulopathy occurs in most patients with (APML) and is life‐threatening; therefore prompt
diagnosis and recognition of any coagulation defect is imperative. Unfortunately …
diagnosis and recognition of any coagulation defect is imperative. Unfortunately …
Disseminated intravascular coagulation: the past, present, and future considerations
Disseminated intravascular coagulation (DIC) has been understood as a consumptive
coagulopathy. However, impaired hemostasis is a component of DIC that occurs in a …
coagulopathy. However, impaired hemostasis is a component of DIC that occurs in a …
Revisited role of microparticles in arterial and venous thrombosis
R Lacroix, C Dubois, AS Leroyer… - … of Thrombosis and …, 2013 - Wiley Online Library
Microparticles (MPs) represent a heterogeneous population of submicronic vesicles that are
released in response to cell activation or apoptosis. MPs harbor a large repertoire of cell …
released in response to cell activation or apoptosis. MPs harbor a large repertoire of cell …